BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE AS PRIMARY INDUCTION THERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA SIGNIFICANTLY DECREASES BONE RESORPTION WHILE SPARING BONE FORMATION AS COMPARED TO THALIDOMIDE-DEXAMETHASONE

被引：0
|
作者：
Tosi, P. [1 ]
Zamagni, E. [1 ]
Tacchetti, P. [1 ]
Perrone, G. [1 ]
Ceccolini, M. [1 ]
Brioli, A. [1 ]
Pallotti, M. [1 ]
Pantani, L. [1 ]
Petrucci, A. [1 ]
Baccarani, M. [1 ]
Cavo, M. [1 ]
机构：
[1] Seragnoli Inst Hematol & Med Oncol, Bologna, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0659
引用
收藏
页码：265 / 265
页数：1
相关论文
共 50 条
  • [1] EFFECT OF THALIDOMIDE-DEXAMETHASONE THERAPY ON BONE MARROW ANGIOGENESIS IN NEWLY DIAGNOSED MULTIPLE MYELOMA
    Ladeb, S.
    Mrad, K.
    Abdelkefi, A.
    Torjemane, L.
    Safra, I.
    Hdiji, S.
    Ben Romdhane, N.
    Mdhaffer, M.
    El Omri, H.
    Ben Othman, T.
    Ben Romdhane, K.
    Ben Abdeladhim, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 512 - 512
  • [2] Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
    Cavo, Michele
    Pantani, Lucia
    Petrucci, Maria Teresa
    Patriarca, Francesca
    Zamagni, Elena
    Donnarumma, Daniela
    Crippa, Claudia
    Boccadoro, Mario
    Perrone, Giulia
    Falcone, Antonietta
    Nozzoli, Chiara
    Zambello, Renato
    Masini, Luciano
    Furlan, Anna
    Brioli, Annamaria
    Derudas, Daniele
    Ballanti, Stelvio
    Dessanti, Maria Laura
    De Stefano, Valerio
    Carella, Angelo Michele
    Marcatti, Magda
    Nozza, Andrea
    Ferrara, Felicetto
    Callea, Vincenzo
    Califano, Catello
    Pezzi, Annalisa
    Baraldi, Anna
    Grasso, Mariella
    Musto, Pellegrino
    Palumbo, Antonio
    [J]. BLOOD, 2012, 120 (01) : 9 - 19
  • [3] Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Induction and Consolidation Therapy Before and After Double Autologous Transplantation In Newly Diagnosed Multiple Myeloma: Results From a Randomized Phase 3 Study
    Cavo, Michele
    Perrone, Giulia
    Buttignol, Silvia
    Calabrese, Elisabetta
    Galli, Monica
    Bringhen, Sara
    Spadano, Tonino
    Baldini, Luca
    Caravita, Tommaso
    Nozzoli, Chiara
    Brioli, Annamaria
    Masini, Luciano
    Furlan, Anna
    Pantani, Lucia
    Derudas, Daniele
    Ballanti, Stelvio
    Pisani, Francesco
    De Stefano, Valerio
    Catania, Gioacchino
    Castagna, Luca
    Ferrara, Felicetto
    Callea, Vincenzo
    Musto, Pellegrino
    Zamagni, Elena
    Baccarani, Michele
    [J]. BLOOD, 2010, 116 (21) : 25 - 25
  • [4] Bortezomib (BOR)-Thalidomide-Dexamethasone (VTD) as induction treatment for newly diagnosed Multiple Myeloma (MM) is associated with a lower rate of Second Primary Malignancies (SPMs) compared to Thalidomide-Dexamethasone (TD)
    Brioli, A.
    Pezzi, A.
    Muegge, L-O
    Derudas, D.
    Petti, M. C.
    Zannetti, B. A.
    Ferrara, F.
    Rocchi, S.
    Nobile, F.
    Baraldi, A.
    Musto, P.
    Lanza, F.
    Mancuso, K.
    Canepa, L.
    Catalano, L.
    Lazzaro, A.
    Pinotti, G.
    Boccadoro, M.
    Hochhaus, A.
    Cavo, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 69 - 69
  • [5] Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma
    Wang, M
    Weber, DM
    Delasalle, K
    Alexanian, R
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2005, 79 (03) : 194 - 197
  • [6] Molecular Remission After Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Consolidation Therapy Following Double Autologous Transplantation for Multiple Myeloma: Results of a Qualitative and Quantitative Analysis
    Terragna, Carolina
    Zamagni, Elena
    Petrucci, Maria Teresa
    Durante, Sandra
    Patriarca, Francesca
    Narni, Franco
    Crippa, Claudia
    Gorgone, Ausilia
    Caravita, Tommaso
    Perrone, Giulia
    Nozzoli, Chiara
    Masini, Luciano
    Callea, Vincenzo
    Attolico, Immacolata
    Cellini, Claudia
    Bringhen, Sara
    Ledda, Antonio
    Montefusco, Vittorio
    Martello, Marina
    Martinelli, Giovanni
    Baccarani, Michele
    Cavo, Michele
    [J]. BLOOD, 2010, 116 (21) : 376 - 376
  • [7] Superiority of Lenalidomide-Dexamethasone Versus Thalidomide-Dexamethasone as Initial Therapy for Newly Diagnosed Multiple Myeloma
    Gay, Francesca
    Hayman, Suzanne
    Lacy, Martha Q.
    Buadi, Francis
    Gertz, Morie A.
    Kumar, Shaji
    Dispenzieri, Angela
    Mikhael, Joseph R.
    Bergsagel, Leif
    Dingli, David
    Reeder, Craig B.
    Lust, John A.
    Russel, Stephen
    Roj, Vivek
    Zeldenrust, Steven R.
    Witzig, Thomas E.
    Fonseca, Rafael
    Kyle, Robert
    Greipp, Philip R.
    Stewart, A. Keith
    Rajkumar, S. Vincent
    [J]. BLOOD, 2009, 114 (22) : 1494 - 1495
  • [8] Bortezomib-Thalidomide-Dexamethasone Incorporated Into Autotransplantation Is Associated with More Favorable Outcomes After Relapse in Comparison with Thalidomide-Dexamethasone Plus Autotransplantation in Multiple Myeloma
    Cavo, Michele
    Galli, Monica
    Pantani, Lucia
    Di Raimondo, Francesco
    Crippa, Claudia
    Offidani, Massimo
    Zamagni, Elena
    Montefusco, Vittorio
    Narni, Franco
    Pezzi, Annalisa
    Spadano, Antonio
    Pescosta, Norbert
    Tacchetti, Paola
    Baldini, Luca
    Ledda, Antonio
    Cellini, Claudia
    Caravita, Tommaso
    Falcone, Antonietta
    Nozzoli, Chiara
    Zambello, Renato
    Masini, Luciano
    Boccadoro, Mario
    [J]. BLOOD, 2012, 120 (21)
  • [9] Bortezomib with Thalidomide plus Dexamethasone Compared with Thalidomide plus Doxorubicin and Dexamethasone as Induction Therapy in Previously Untreated Multiple Myeloma Patients
    Buda, Gabriele
    Orciuolo, Enrico
    Carulli, Giovanni
    Galimberti, Sara
    Ghio, Francesco
    Cervetti, Giulia
    Pelosini, Matteo
    Petrini, Mario
    [J]. ACTA HAEMATOLOGICA, 2013, 129 (01) : 35 - 39
  • [10] BORTEZOMIB PLUS DEXAMETHASONE VERSUS REDUCED-DOSE BORTEZOMIB PLUS THALIDOMIDE-DEXAMETHASONE AS INDUCTION PRIOR TO AUTOLOGOUS TRANSPLANTATION IN NEWLY DIAGNOSED MYELOMA
    Harousseau, J. L.
    Avet-Loiseau, H.
    Mary, J.
    Facon, T.
    Attal, M.
    Doyen, C.
    Hulin, C.
    Garderet, L.
    Tiab, M.
    Lepeu, G.
    Araujo, C.
    Caillot, D.
    Petillon, M.
    Mathiot, C.
    Moreau, P.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 451 - 451
12345